Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Hypoxia × Exercise × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Motor Activity 9 Neoplasms 4 Breast Neoplasms 3 Weight Loss 1 Ventricular Dysfunction, Left 1 Urinary Incontinence 1 Sexual Dysfunction, Physiological 1 Sarcoma 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Polycystic Ovary Syndrome 1 Ovarian Neoplasms 1 Lymphoma 1 Leukemia 1 Insulin Resistance 1 Hypoxia 1 Hematologic Neoplasms 1 Heart Failure 1 Head and Neck Neoplasms 1 Fecal Incontinence 1 Fatigue 1 Cardiotoxicity 1 Carcinoma, Renal Cell 1 Brenner Tumor 1 Breast Diseases 1 Brain Neoplasms 1 Bone Metastases 1 Body Weight 1 Asthenia 1

Interventions

Injections 2 3-fluoro-2-(4-((2-nitro-1H-imidazol-1-yl)methyl)-1H-1,2,3-triazol-1-yl)propan-1-ol 2 alovudine 1 Nitroglycerin 1 Magnetic Resonance Spectroscopy 1 Exercise 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03365076 2023-01-09

EXIPOX

University Hospital of North Norway

Phase NA Terminated

Hypoxia, Motor Activity, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡